Mairs, R. , Fullerton, N., Cosimo, E. and Boyd, M. (2005) Gene manipulation to enhance MIBG-targeted radionuclide therapy. Nuclear Medicine and Biology, 32(7), pp. 749-753. (doi: 10.1016/j.nucmedbio.2005.03.011)
Full text not currently available from Enlighten.
Abstract
The goal of targeted radionuclide therapy is the deposition in malignant cells of sterilizing doses of radiation without damaging normal tissue. The radiopharmaccutical [I-131] meta-iodobenzylguanidine ([I-131]MIBG) is an effective single agent for the treatment of neuroblastoma. However, uptake of the drug in malignant sites is insufficient to cure disease. A growing body of experimental evidence indicates exciting possibilities for the integration of gene transfer with [I-131]MIBG-targeted radiotherapy.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Mairs, Professor Robert and Boyd, Dr Marie |
Authors: | Mairs, R., Fullerton, N., Cosimo, E., and Boyd, M. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Nuclear Medicine and Biology |
ISSN: | 0969-8051 |
University Staff: Request a correction | Enlighten Editors: Update this record